✦ LIBER ✦

Impact of Rofecoxib Withdrawal on Cyclooxygenase-2 Utilization among Patients with and without Cardiovascular Risk

✍ Scribed by Patrick Thiebaud; Bimal V. Patel; Michael B. Nichol

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV7 Impact of Comorbidities on Risk of

✍ M. Panaccio; G. Cummins; R. Miao; P. Davis; C. Wentworth; S. Lanes; M. Reynolds; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

RM2 IMPACT OF ADHERENCE WITH STATIN THER

✍ Y Yang; BF Banahan; PF Pace 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB26 THE IMPACT OF VASCULAR EVENTS ON H

✍ CJ Currie; JR Peters; M Morrissey; K Bergenheim; P McEwan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PDB72 The Impact on Utilities of Weight

✍ S. Lane; A.R. Levy; J. Sambrook; J. Mukherjee; M. Leahy; H. Tildesley 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

RISK OF CARDIOVASCULAR EVENTS IN CORONAR

✍ Singh, Mukesh; Shah, Tejaskumar; Adigopula, Sasikanth; Jawad, Evyan; Khosla, San 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Tu-W19:4 Impact of metformin versus repa

✍ Lund, S.; Tarnow, L.; Poulsen, G.; Stehouwer, C.; Schalkwijk, C.; Gram, J.; Smid 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB